http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 02 Oct 2025 04:46:44 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Options/Spdr+S%26p+Pharmaceuticals+Etf+%28XPH%29+30-day+option+implied+volatility+as+share+price+up/25408813.html <p>Spdr S&p Pharmaceuticals Etf (NYSE: XPH) 30-day option implied volatility is at 18; compared to its 52-week range of 14 to 43 as share price up.</p> http://www.streetinsider.com/Options/Spdr+S%26p+Pharmaceuticals+Etf+%28XPH%29+30-day+option+implied+volatility+as+share+price+up/25408813.html Thu, 02 Oct 2025 04:46:44 -0400 XPH http://www.streetinsider.com/Options/Spdr+S%26p+Pharmaceuticals+Etf+%28XPH%29+30-day+option+implied+volatility+low%2C+share+price+up+1.2%25/25404511.html <p>Spdr S&p Pharmaceuticals Etf (NYSE: XPH) 30-day option implied volatility is at 18; compared to its 52-week range of 14 to 43 as share price up 1.2%.</p> http://www.streetinsider.com/Options/Spdr+S%26p+Pharmaceuticals+Etf+%28XPH%29+30-day+option+implied+volatility+low%2C+share+price+up+1.2%25/25404511.html Wed, 01 Oct 2025 10:16:38 -0400 XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/Investing/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html <p>Investing.com -- Pharmaceutical stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts cautioned that the sector is not in the clear, as targeted levies may still be on the horizon.</p> <p>Trump’s latest tariff package included a 10% duty on most U.S. imports and significantly higher rates on goods from various trading partners. Pharmaceuticals were among a handful of categories granted a temporary exemption—an outcome that favored key exporters like India, Japan, and Ireland.</p> <p>U.S. drugmakers traded relatively flat in premarket trading, with Amgen (NASDAQ:AMGN) and Johnson&amp;Johnson http://www.streetinsider.com/General+News/Pharma+stocks+up+on+US+tariff+exemptions+but+analyst+flags+a+%2446B+import+cost+risk/24594868.html Thu, 03 Apr 2025 08:07:39 -0400 ABBV AMGN AZN BIIB IHE JAZZ JNJ MRK NVO PFE REGN XPH